Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Global Patient Registry Software Market $3.6 Billion by 2031

The global market for patient registry software estimated to reach $3.6 billion by 2031, expanding at a CAGR of 8.2% over the forecast period, driven by increasing prevalence and incidence of chronic diseases such as diabetes, cancer, cardiovascular disorders and infectious diseases.

  • Other factors driving the market growth include the unmet need in assessing clinical effectiveness and cost-effectiveness during disease treatment, need for efficient management patient record keeping solutions, and government support in patient database management.
Global Patient Registry Software Market

Patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. 

  • It is a powerful tool to observe the course of disease; to understand variations in treatment and outcomes; to examine factors that influence prognosis and quality of life; to describe care patterns, including appropriateness of care and disparities in the delivery of care; to assess effectiveness; to monitor safety and harm; and to measure quality of care.

The patient registries are designed and evaluated with respect to their intended purpose(s) which can be broadly described in terms of patient outcomes. Patient registries are a widespread and important instrument in medical research, clinical epidemiology, and quality management.

  • For example, product registries include patients who have been exposed to biopharmaceutical products, medical devices or diagnostic/therapeutic equipment.
    • Health services registries consist of patients with a common procedure, clinical encounter, or hospitalization.
      • Disease or condition registries includes patients having the same diagnosis, such as cystic fibrosis or heart failure, or same group of conditions such as disability.
        • Patient registries are a key component of patient-centric care and can come in many forms such as disease-specific, recruitment, clinical, contact, post market and surveillance. 
  • Some of the major general purposes for establishing and running a patient registry are to describe the natural history of disease, to determine clinical and/or cost-effectiveness, to assess safety or harm, and to measure quality of care, as well as to serve public health surveillance and disease control.
    • The number of medical registries is constantly increasing, which demonstrates their cumulative importance over the last years. Medical registries serve different purposes, among others public health, epidemiology, quality control, clinical registries, disease-specific registries, etc.
      • They present different conceptual and technical challenges for example interoperability, data quality, security, protection of data privacy, etc.

The global patient registry software market report provides market size ($million 2021 to 2031), market share, growth trends and forecast (CAGR%, 2024 to 2031). 

The global market for patient registry software segmented by disease/ condition (cancer registry, cardiovascular diseases registry, diabetes registry, orphan diseases registry, other chronic diseases registry), registry type (public and private domain), end user (government and private / commercial), and geography.

  • By disease- or condition-based registry types, the diabetes patient registry segment dominated the overall patient registry software market and also expected to witness fastest growth rate throughout the forecast period.
    • Diabetes registries monitor the population prevalence and incidence of diabetes, monitor diabetes control program, provide information of quality of care to health service providers, and provide a sampling frame for interventional studies.
      • Diabetes registries are increasingly being utilized as a critical feature for population-based disease management. 
      • For example, the diabetes registries have been used by small clinics as well as large health plans, such as Kaiser-Permanente, which has more than 260,000 patients in its diabetes registry.
        • A diabetes registry can be used to target high-risk patients, send reminders to patients, and provide physicians with feedback on their care, all important aspects of an optimal diabetes registry that can lead to significant improvements in clinical outcomes.
  • Based on registry types, the private- or commercial registry software accounted for the largest revenue segment of the total patient registry software market.
    • However, the public domain registry software segment anticipated to be the fastest growing market with double-digit CAGR during the forecast period.
      • Commercial and open-source systems are available for registry implementation, but many research groups develop their own systems. 
  • In terms of end users, the public or government-based segment led the total patient registry software market with largest revenue share, whereas the private- or commercial end users segment is anticipated to be the fastest growing market over the forecast period.

The global patient registry software market research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • The United States has more than 1,000 free medical clinics. Because these clinics do not bill Medicare or Medicaid, they are not eligible for federal reimbursement for electronic health record (EHR) adoption. As a result, most do not have EHRs or electronic disease registries.
  • With the advent of electronic health records (EHRs), it is likely that some clinics are tracking chronic diseases with registries that are a feature of their EHR systems.
    • However, free clinics are not eligible to receive federal government reimbursement for EHR use, and little is known about EHR usage by free clinics. It is likely that free clinics that use EHRs are associated with large healthcare systems that share their software.
  • On the other hand, several noncommercial diabetes registries that could be used by free clinics are available in the United States.
    • For instance, the Diabetes Collaborative Registry is a global cross-disciplinary registry endorsed by several medical specialty organizations such as American Diabetes Association (ADA), American Association of Clinical Endocrinologists (AACE), Joslin Diabetes Center, American College of Physicians (ACP), and sponsored by two pharmaceutical companies (AstraZeneca and Boehringer Ingelheim).

The global patient registry software market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for patient registry software and included in this report are Dacima Software, Inc., Evado Clinical Software (Evado eClinical Solutions), Global Vision Technologies, Inc., IQVIA (IMS Health, Inc./Quintiles, Inc.), and PatientCrossroads, Inc. (Invitae Corporation).

  • Disease / Condition / Registry
    • Cancer Registry
    • Cardiovascular Disorders Registry
    • Diabetes Registry
    • Orphan (Rare) Diseases Registry
    • Other Chronic Diseases Registry
  • Registry
    • Public Domain
    • Private Domain / Commercial
  • End User
    • Government / Public
    • Private / Commercial
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Dacima Software, Inc.
    • Evado Clinical Software (Evado eClinical Solutions)
    • Global Vision Technologies, Inc.
    • IQVIA (IMS Health, Inc./Quintiles, Inc.)
    • PatientCrossroads, Inc. (Invitae Corporation)

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com